PATENT CLAIM ANALYSIS

Application Number: 15755374
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "422000"]

Abstract:
The invention discloses naltrexone implantable tablets which are devoid of metal salts and corticosteroids, and which provide consistent and controlled amount of naltrexone for 3 months or more; also disclosed is methods of treatment comprising the implants and methods of sterilization of the implants.

Claim (Index 4):
The Naltrexone implantable tablet composition according to  claim 3 , wherein, the polymer is DL-Lactide/Glycolide Co-Polymer of variable compositions selected from the group consisting of 50:50, 65:35, 75:25, 85:15, 5:95, 15:85 and 25:75.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10363107', '12336267', '15245338', '15715425', '14490493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7337058038651464
- 35 USC 102 Novelty (BERT): 0.4834234451540976
- Combined Prediction Score: 0.7086775679940415
- Mean Citation Score: 168.794826
- Max Citation Score: 178.20898
- Similarity Product: 122.96890135786296

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test